FangzhnengChen
Lv11
40 积分
2023-04-10 加入
-
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
3小时前
已完结
-
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099
4个月前
已完结
-
Advances and challenges in immunotherapy for locally advanced nasopharyngeal carcinoma
4个月前
已完结
-
Drug delivery for platinum therapeutics
5个月前
已完结
-
Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification
9个月前
已完结
-
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial
9个月前
已完结
-
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial
10个月前
已完结
-
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1年前
已完结
-
Development of the Ninth Version of the Nasopharyngeal Cancer TNM Staging System by the American Joint Committee on Cancer and Union for International Cancer Control (AJCC/UICC): Recommendations Based on a Multicenter Validation Study and Clinical Considerations
1年前
已关闭
-
Revisiting TNM staging for EBV-related nasopharyngeal carcinoma
1年前
已完结